| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Nucleus | 36 | 2024 | 629 | 7.410 |
Why?
|
| Cell Nucleolus | 26 | 2023 | 70 | 6.370 |
Why?
|
| Cell Biology | 10 | 2024 | 22 | 6.010 |
Why?
|
| History, 20th Century | 43 | 2024 | 231 | 5.130 |
Why?
|
| Molecular Biology | 12 | 2020 | 67 | 4.440 |
Why?
|
| History, 21st Century | 31 | 2024 | 172 | 3.980 |
Why?
|
| RNA | 19 | 2021 | 423 | 3.170 |
Why?
|
| Genome | 9 | 2022 | 276 | 2.890 |
Why?
|
| Science | 5 | 2022 | 34 | 2.850 |
Why?
|
| RNA, Messenger | 19 | 2021 | 1537 | 2.640 |
Why?
|
| Periodicals as Topic | 7 | 2022 | 175 | 2.500 |
Why?
|
| Humans | 134 | 2024 | 63458 | 2.490 |
Why?
|
| Genome, Human | 6 | 2020 | 237 | 2.280 |
Why?
|
| Microscopy, Fluorescence | 9 | 2020 | 401 | 2.190 |
Why?
|
| Cell Cycle | 9 | 2019 | 392 | 2.160 |
Why?
|
| Ribosomes | 12 | 2019 | 163 | 2.160 |
Why?
|
| Nobel Prize | 7 | 2024 | 12 | 2.150 |
Why?
|
| Biochemistry | 5 | 2021 | 50 | 2.000 |
Why?
|
| Chromosomes, Human | 4 | 2019 | 52 | 1.850 |
Why?
|
| Biology | 4 | 2022 | 27 | 1.800 |
Why?
|
| Research | 5 | 2021 | 193 | 1.770 |
Why?
|
| Publications | 4 | 2019 | 29 | 1.740 |
Why?
|
| DNA Repair | 6 | 2022 | 248 | 1.740 |
Why?
|
| DNA | 9 | 2022 | 837 | 1.730 |
Why?
|
| Nuclear Proteins | 13 | 2018 | 778 | 1.620 |
Why?
|
| Terminology as Topic | 3 | 2020 | 141 | 1.610 |
Why?
|
| Fluorescent Dyes | 6 | 2020 | 200 | 1.550 |
Why?
|
| Genomics | 4 | 2022 | 369 | 1.540 |
Why?
|
| Genetics, Medical | 2 | 2022 | 11 | 1.520 |
Why?
|
| Animals | 64 | 2024 | 20663 | 1.490 |
Why?
|
| Neoplasms | 6 | 2019 | 1364 | 1.430 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 3 | 2017 | 99 | 1.370 |
Why?
|
| Women's Health Services | 2 | 2023 | 30 | 1.370 |
Why?
|
| Signal Recognition Particle | 9 | 2011 | 39 | 1.360 |
Why?
|
| Biomedical Research | 3 | 2018 | 268 | 1.300 |
Why?
|
| Publishing | 3 | 2020 | 93 | 1.270 |
Why?
|
| Chromosomes | 5 | 2022 | 135 | 1.260 |
Why?
|
| Drug Industry | 2 | 2021 | 39 | 1.250 |
Why?
|
| Biological Evolution | 3 | 2022 | 122 | 1.190 |
Why?
|
| Carrier Proteins | 5 | 2022 | 707 | 1.180 |
Why?
|
| RNA, Transfer | 6 | 2016 | 89 | 1.160 |
Why?
|
| Women's Health | 3 | 2021 | 370 | 1.160 |
Why?
|
| RNA, Ribosomal | 10 | 2014 | 56 | 1.150 |
Why?
|
| Portraits as Topic | 7 | 2022 | 13 | 1.130 |
Why?
|
| United States | 22 | 2024 | 7843 | 1.130 |
Why?
|
| Cardiology | 2 | 2020 | 168 | 1.130 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2021 | 117 | 1.120 |
Why?
|
| Research Personnel | 4 | 2020 | 94 | 1.110 |
Why?
|
| Protein Biosynthesis | 7 | 2016 | 320 | 1.110 |
Why?
|
| Transcription, Genetic | 9 | 2022 | 878 | 1.080 |
Why?
|
| Artificial Intelligence | 2 | 2021 | 179 | 0.990 |
Why?
|
| MicroRNAs | 6 | 2016 | 687 | 0.980 |
Why?
|
| In Situ Hybridization | 8 | 2019 | 216 | 0.970 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 1617 | 0.970 |
Why?
|
| Schizophrenia | 2 | 2018 | 263 | 0.920 |
Why?
|
| Physicians | 2 | 2020 | 470 | 0.900 |
Why?
|
| Chromatin | 10 | 2020 | 608 | 0.880 |
Why?
|
| Osteosarcoma | 2 | 2019 | 58 | 0.870 |
Why?
|
| Scientific Misconduct | 2 | 2019 | 12 | 0.870 |
Why?
|
| Congresses as Topic | 2 | 2024 | 79 | 0.850 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2022 | 43 | 0.850 |
Why?
|
| Research Support as Topic | 3 | 2019 | 42 | 0.850 |
Why?
|
| Politics | 2 | 2021 | 35 | 0.840 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2014 | 81 | 0.840 |
Why?
|
| Patents as Topic | 2 | 2021 | 7 | 0.830 |
Why?
|
| CRISPR-Cas Systems | 2 | 2018 | 361 | 0.830 |
Why?
|
| Reproductive Health Services | 1 | 2023 | 13 | 0.830 |
Why?
|
| Staining and Labeling | 4 | 2016 | 126 | 0.820 |
Why?
|
| Drug Discovery | 2 | 2021 | 95 | 0.820 |
Why?
|
| Cytoplasm | 6 | 2020 | 276 | 0.820 |
Why?
|
| Transcriptional Activation | 2 | 2014 | 190 | 0.800 |
Why?
|
| Peer Review, Research | 3 | 2020 | 47 | 0.800 |
Why?
|
| Famous Persons | 2 | 2016 | 6 | 0.790 |
Why?
|
| Mitosis | 3 | 2019 | 218 | 0.780 |
Why?
|
| Laboratory Personnel | 1 | 2022 | 2 | 0.760 |
Why?
|
| Vaccination | 2 | 2022 | 362 | 0.760 |
Why?
|
| Mass Media | 1 | 2022 | 31 | 0.740 |
Why?
|
| Heredity | 2 | 2024 | 6 | 0.730 |
Why?
|
| Spliceosomes | 2 | 2017 | 42 | 0.730 |
Why?
|
| Centrioles | 2 | 2020 | 26 | 0.720 |
Why?
|
| Actins | 5 | 2013 | 259 | 0.720 |
Why?
|
| Awards and Prizes | 1 | 2021 | 34 | 0.700 |
Why?
|
| Knowledge | 1 | 2021 | 31 | 0.700 |
Why?
|
| Life Expectancy | 1 | 2021 | 32 | 0.700 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 150 | 0.690 |
Why?
|
| Gender Identity | 1 | 2021 | 67 | 0.680 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2022 | 445 | 0.680 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 24 | 0.680 |
Why?
|
| RNA Splicing | 3 | 2017 | 162 | 0.680 |
Why?
|
| Cytological Techniques | 2 | 2019 | 26 | 0.680 |
Why?
|
| Rats | 18 | 2020 | 1981 | 0.680 |
Why?
|
| Biological Products | 1 | 2022 | 95 | 0.670 |
Why?
|
| Transfection | 4 | 2020 | 694 | 0.670 |
Why?
|
| Vaccines, Synthetic | 1 | 2020 | 78 | 0.670 |
Why?
|
| Human Genetics | 1 | 2020 | 2 | 0.660 |
Why?
|
| Longevity | 1 | 2021 | 113 | 0.650 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2020 | 39 | 0.650 |
Why?
|
| Drug Repositioning | 1 | 2020 | 8 | 0.650 |
Why?
|
| Medical Writing | 1 | 2019 | 2 | 0.640 |
Why?
|
| Pandemics | 2 | 2022 | 671 | 0.630 |
Why?
|
| Racism | 1 | 2021 | 88 | 0.630 |
Why?
|
| Theft | 1 | 2019 | 2 | 0.630 |
Why?
|
| Intellectual Property | 1 | 2019 | 6 | 0.630 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.630 |
Why?
|
| Fees and Charges | 1 | 2019 | 17 | 0.620 |
Why?
|
| Financial Management | 1 | 2019 | 6 | 0.620 |
Why?
|
| Homeostasis | 1 | 2022 | 368 | 0.620 |
Why?
|
| Myoblasts | 4 | 2014 | 64 | 0.620 |
Why?
|
| Societies | 1 | 2019 | 24 | 0.610 |
Why?
|
| Genetics | 2 | 2018 | 13 | 0.610 |
Why?
|
| Protein Folding | 1 | 2021 | 267 | 0.610 |
Why?
|
| Education, Graduate | 1 | 2019 | 16 | 0.610 |
Why?
|
| Biological Science Disciplines | 1 | 2019 | 4 | 0.610 |
Why?
|
| Phage Therapy | 1 | 2019 | 1 | 0.610 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 192 | 0.600 |
Why?
|
| Public Health | 1 | 2020 | 187 | 0.590 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 396 | 0.590 |
Why?
|
| Cobalt | 1 | 2018 | 16 | 0.580 |
Why?
|
| Hematology | 1 | 2018 | 12 | 0.580 |
Why?
|
| Schools | 1 | 2019 | 166 | 0.580 |
Why?
|
| RNA Precursors | 6 | 2013 | 76 | 0.580 |
Why?
|
| RNA Interference | 2 | 2017 | 618 | 0.580 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 385 | 0.580 |
Why?
|
| Sex Factors | 1 | 2021 | 980 | 0.580 |
Why?
|
| History, 19th Century | 5 | 2021 | 43 | 0.580 |
Why?
|
| tau Proteins | 1 | 2019 | 201 | 0.580 |
Why?
|
| Foundations | 1 | 2018 | 9 | 0.570 |
Why?
|
| Molecular Imaging | 1 | 2018 | 48 | 0.570 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.570 |
Why?
|
| Mentoring | 1 | 2019 | 49 | 0.570 |
Why?
|
| Cell Physiological Phenomena | 2 | 2016 | 12 | 0.570 |
Why?
|
| Protein Conformation | 1 | 2021 | 779 | 0.570 |
Why?
|
| Ribosomal Proteins | 5 | 2014 | 43 | 0.570 |
Why?
|
| Reproductive Medicine | 1 | 2017 | 5 | 0.560 |
Why?
|
| Viruses | 1 | 2019 | 81 | 0.560 |
Why?
|
| Fertilization in Vitro | 1 | 2018 | 85 | 0.560 |
Why?
|
| Aromatase | 1 | 2017 | 14 | 0.560 |
Why?
|
| Disease | 1 | 2017 | 27 | 0.550 |
Why?
|
| Hemoglobinopathies | 1 | 2017 | 7 | 0.550 |
Why?
|
| Contraceptive Agents, Female | 1 | 2018 | 24 | 0.550 |
Why?
|
| Bacteriophages | 1 | 2019 | 62 | 0.550 |
Why?
|
| Biophysical Phenomena | 2 | 2015 | 23 | 0.550 |
Why?
|
| Cells | 2 | 2016 | 32 | 0.550 |
Why?
|
| DNA Restriction Enzymes | 2 | 2017 | 34 | 0.540 |
Why?
|
| Pharmaceutical Services | 1 | 2017 | 33 | 0.540 |
Why?
|
| Gastric Acid | 1 | 2017 | 10 | 0.540 |
Why?
|
| Evolution, Molecular | 3 | 2010 | 322 | 0.540 |
Why?
|
| Drug Costs | 1 | 2017 | 56 | 0.540 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 45 | 0.540 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2008 | 309 | 0.540 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 90 | 0.540 |
Why?
|
| Introns | 1 | 2017 | 111 | 0.530 |
Why?
|
| Bacterial Infections | 1 | 2019 | 149 | 0.530 |
Why?
|
| Malaria | 1 | 2019 | 148 | 0.530 |
Why?
|
| Antacids | 1 | 2017 | 14 | 0.530 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 222 | 0.530 |
Why?
|
| Students | 1 | 2019 | 217 | 0.530 |
Why?
|
| Ecology | 1 | 2016 | 14 | 0.520 |
Why?
|
| Chemistry, Bioinorganic | 1 | 2016 | 2 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 209 | 0.520 |
Why?
|
| Embryology | 1 | 2016 | 3 | 0.520 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.520 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 317 | 0.520 |
Why?
|
| Physics | 1 | 2016 | 12 | 0.520 |
Why?
|
| Proteins | 2 | 2021 | 750 | 0.510 |
Why?
|
| Eukaryotic Cells | 2 | 2014 | 57 | 0.510 |
Why?
|
| Academies and Institutes | 1 | 2016 | 25 | 0.510 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 124 | 0.500 |
Why?
|
| RNA, Untranslated | 3 | 2017 | 103 | 0.500 |
Why?
|
| Inheritance Patterns | 1 | 2016 | 19 | 0.500 |
Why?
|
| Developmental Biology | 1 | 2016 | 6 | 0.490 |
Why?
|
| Public Policy | 1 | 2016 | 41 | 0.490 |
Why?
|
| Signal Transduction | 3 | 2022 | 3035 | 0.490 |
Why?
|
| Glycolysis | 1 | 2016 | 56 | 0.490 |
Why?
|
| Bacteria | 1 | 2019 | 306 | 0.480 |
Why?
|
| Genes | 1 | 2015 | 90 | 0.480 |
Why?
|
| Endonucleases | 1 | 2016 | 84 | 0.480 |
Why?
|
| Influenza, Human | 1 | 2018 | 208 | 0.470 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 158 | 0.470 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 678 | 0.470 |
Why?
|
| Chemistry | 1 | 2015 | 31 | 0.460 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2015 | 32 | 0.460 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 462 | 0.460 |
Why?
|
| Curriculum | 1 | 2019 | 599 | 0.460 |
Why?
|
| Virus Replication | 2 | 2020 | 321 | 0.450 |
Why?
|
| Heart Diseases | 1 | 2017 | 218 | 0.450 |
Why?
|
| Tritium | 2 | 2014 | 22 | 0.450 |
Why?
|
| Biophysics | 1 | 2014 | 42 | 0.450 |
Why?
|
| Thymidine | 2 | 2014 | 25 | 0.450 |
Why?
|
| Models, Biological | 3 | 2016 | 1180 | 0.450 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2014 | 4 | 0.450 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 246 | 0.440 |
Why?
|
| DNA, Satellite | 1 | 2014 | 16 | 0.430 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 289 | 0.430 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 22 | 0.430 |
Why?
|
| RNA Processing, Post-Transcriptional | 4 | 2003 | 103 | 0.420 |
Why?
|
| HeLa Cells | 8 | 2023 | 536 | 0.420 |
Why?
|
| Poliovirus Vaccines | 1 | 2013 | 4 | 0.420 |
Why?
|
| Poliomyelitis | 1 | 2013 | 3 | 0.420 |
Why?
|
| Pain | 1 | 2016 | 406 | 0.410 |
Why?
|
| Symbiosis | 1 | 2013 | 32 | 0.410 |
Why?
|
| Eukaryota | 1 | 2013 | 29 | 0.410 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2013 | 5 | 0.410 |
Why?
|
| DNA Damage | 4 | 2022 | 287 | 0.400 |
Why?
|
| Glucose | 1 | 2016 | 467 | 0.400 |
Why?
|
| Bone Neoplasms | 2 | 2019 | 125 | 0.400 |
Why?
|
| Histocytochemistry | 3 | 2004 | 47 | 0.390 |
Why?
|
| DNA, Antisense | 1 | 2012 | 17 | 0.390 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 721 | 0.380 |
Why?
|
| Biotechnology | 1 | 2012 | 44 | 0.380 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2015 | 115 | 0.380 |
Why?
|
| Gene Expression | 4 | 2024 | 840 | 0.380 |
Why?
|
| RNA, Small Nuclear | 3 | 2002 | 25 | 0.380 |
Why?
|
| Protein Kinases | 1 | 2013 | 152 | 0.370 |
Why?
|
| GTP-Binding Proteins | 5 | 2014 | 84 | 0.370 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 1469 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 174 | 0.370 |
Why?
|
| Gene Editing | 1 | 2016 | 321 | 0.370 |
Why?
|
| Advisory Committees | 1 | 2012 | 112 | 0.360 |
Why?
|
| Sea Urchins | 2 | 2013 | 35 | 0.360 |
Why?
|
| Television | 1 | 2011 | 21 | 0.350 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5461 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2013 | 191 | 0.350 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 536 | 0.350 |
Why?
|
| Genetic Therapy | 1 | 2018 | 791 | 0.350 |
Why?
|
| Ribonucleoproteins | 4 | 2013 | 114 | 0.340 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2010 | 9 | 0.340 |
Why?
|
| Communication | 2 | 2016 | 572 | 0.340 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 768 | 0.330 |
Why?
|
| Information Dissemination | 1 | 2011 | 116 | 0.330 |
Why?
|
| Tetrahymena | 1 | 2010 | 6 | 0.330 |
Why?
|
| HEK293 Cells | 3 | 2022 | 622 | 0.320 |
Why?
|
| Nuclear Envelope | 4 | 2011 | 49 | 0.320 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2020 | 6 | 0.310 |
Why?
|
| Telomerase | 3 | 2006 | 31 | 0.310 |
Why?
|
| Inflammation | 1 | 2016 | 1147 | 0.310 |
Why?
|
| RNA Transport | 2 | 2006 | 31 | 0.300 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 507 | 0.300 |
Why?
|
| Health Promotion | 1 | 2013 | 497 | 0.300 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2008 | 182 | 0.280 |
Why?
|
| Medical Staff | 1 | 2008 | 13 | 0.280 |
Why?
|
| Mutation | 4 | 2018 | 2611 | 0.280 |
Why?
|
| Biological Transport | 8 | 2003 | 291 | 0.280 |
Why?
|
| Actin Cytoskeleton | 1 | 2008 | 76 | 0.280 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2007 | 9 | 0.270 |
Why?
|
| China | 2 | 2019 | 162 | 0.270 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1186 | 0.270 |
Why?
|
| Cell Line | 9 | 2020 | 2040 | 0.270 |
Why?
|
| G1 Phase | 1 | 2007 | 56 | 0.270 |
Why?
|
| Binding Sites | 3 | 2018 | 905 | 0.260 |
Why?
|
| Genetic Code | 1 | 2006 | 6 | 0.260 |
Why?
|
| Peer Review | 1 | 2007 | 26 | 0.260 |
Why?
|
| Physician's Role | 1 | 2008 | 124 | 0.250 |
Why?
|
| Statistics as Topic | 1 | 2007 | 145 | 0.250 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 79 | 0.250 |
Why?
|
| Cell Nucleus Structures | 1 | 2005 | 2 | 0.250 |
Why?
|
| Microscopy | 1 | 2006 | 91 | 0.250 |
Why?
|
| Authorship | 1 | 2006 | 23 | 0.250 |
Why?
|
| Centrosome | 1 | 2006 | 71 | 0.240 |
Why?
|
| Faculty, Medical | 1 | 2008 | 198 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 525 | 0.230 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2005 | 58 | 0.230 |
Why?
|
| DNA Replication | 3 | 2018 | 236 | 0.230 |
Why?
|
| Amino Acids | 1 | 2005 | 147 | 0.220 |
Why?
|
| RNA, Nuclear | 3 | 2017 | 13 | 0.220 |
Why?
|
| Coiled Bodies | 1 | 2004 | 4 | 0.220 |
Why?
|
| Female | 8 | 2023 | 32884 | 0.220 |
Why?
|
| Forecasting | 2 | 2016 | 232 | 0.210 |
Why?
|
| Histones | 2 | 2020 | 481 | 0.210 |
Why?
|
| Base Sequence | 5 | 2016 | 1331 | 0.210 |
Why?
|
| Plant Roots | 1 | 2024 | 63 | 0.210 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2680 | 0.210 |
Why?
|
| Green Fluorescent Proteins | 3 | 2016 | 367 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 542 | 0.200 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 158 | 0.200 |
Why?
|
| Nova Scotia | 1 | 2022 | 2 | 0.200 |
Why?
|
| Brain | 1 | 2011 | 1552 | 0.190 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2157 | 0.190 |
Why?
|
| Alkylating Agents | 1 | 2022 | 10 | 0.190 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 59 | 0.190 |
Why?
|
| Mutagens | 1 | 2022 | 20 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2013 | 234 | 0.190 |
Why?
|
| Ecdysterone | 1 | 2001 | 11 | 0.180 |
Why?
|
| Religion | 1 | 2021 | 30 | 0.180 |
Why?
|
| Hormones | 1 | 2001 | 60 | 0.180 |
Why?
|
| Ultraviolet Rays | 1 | 2022 | 137 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 663 | 0.170 |
Why?
|
| Trust | 1 | 2021 | 73 | 0.170 |
Why?
|
| Proteome | 1 | 2002 | 150 | 0.170 |
Why?
|
| Aerosols | 1 | 2021 | 47 | 0.170 |
Why?
|
| Government | 1 | 2020 | 8 | 0.170 |
Why?
|
| History, 18th Century | 1 | 2020 | 9 | 0.170 |
Why?
|
| Ascaris | 1 | 2020 | 4 | 0.170 |
Why?
|
| Ferns | 1 | 2020 | 2 | 0.170 |
Why?
|
| United Arab Emirates | 1 | 2020 | 4 | 0.170 |
Why?
|
| Molecular Sequence Data | 6 | 2002 | 1991 | 0.170 |
Why?
|
| Telomere | 2 | 2013 | 52 | 0.170 |
Why?
|
| Alternative Splicing | 2 | 2017 | 127 | 0.170 |
Why?
|
| Self Concept | 1 | 2020 | 111 | 0.160 |
Why?
|
| Nuclear Matrix | 1 | 2000 | 28 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 113 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2003 | 379 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2020 | 6 | 0.160 |
Why?
|
| Serine-Arginine Splicing Factors | 2 | 2013 | 14 | 0.160 |
Why?
|
| Immunogenetics | 1 | 1999 | 4 | 0.160 |
Why?
|
| Journalism, Medical | 1 | 2019 | 4 | 0.160 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 2 | 2014 | 8 | 0.160 |
Why?
|
| Blood Coagulation | 1 | 2020 | 39 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 327 | 0.160 |
Why?
|
| Editorial Policies | 1 | 2020 | 55 | 0.160 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 17 | 0.160 |
Why?
|
| Xenopus | 1 | 2019 | 55 | 0.160 |
Why?
|
| Federal Government | 1 | 2019 | 19 | 0.160 |
Why?
|
| Zoology | 1 | 2019 | 1 | 0.160 |
Why?
|
| Insecticides | 1 | 2020 | 44 | 0.160 |
Why?
|
| Ownership | 1 | 2019 | 19 | 0.160 |
Why?
|
| Illinois | 1 | 2019 | 13 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2020 | 88 | 0.150 |
Why?
|
| Mosquito Vectors | 1 | 2019 | 13 | 0.150 |
Why?
|
| Parasitology | 1 | 2019 | 4 | 0.150 |
Why?
|
| Nucleic Acids | 1 | 2020 | 60 | 0.150 |
Why?
|
| Conflict of Interest | 1 | 2019 | 37 | 0.150 |
Why?
|
| Cytosol | 1 | 2020 | 180 | 0.150 |
Why?
|
| Anopheles | 1 | 2019 | 21 | 0.150 |
Why?
|
| International Cooperation | 1 | 2019 | 90 | 0.150 |
Why?
|
| Amino Acid Sequence | 2 | 2022 | 1592 | 0.150 |
Why?
|
| New York | 1 | 2019 | 144 | 0.150 |
Why?
|
| Molecular Structure | 1 | 2020 | 384 | 0.150 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Oligonucleotide Probes | 4 | 2020 | 42 | 0.150 |
Why?
|
| Growth Substances | 1 | 1998 | 34 | 0.150 |
Why?
|
| Interphase | 1 | 2019 | 66 | 0.150 |
Why?
|
| Cloning, Organism | 1 | 2018 | 6 | 0.150 |
Why?
|
| A549 Cells | 1 | 2018 | 39 | 0.150 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2018 | 15 | 0.150 |
Why?
|
| Plasmids | 3 | 2013 | 292 | 0.150 |
Why?
|
| 3' Untranslated Regions | 1 | 1999 | 94 | 0.150 |
Why?
|
| Mutagenesis | 1 | 1999 | 133 | 0.150 |
Why?
|
| Influenza Pandemic, 1918-1919 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Vitamin B 12 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 456 | 0.140 |
Why?
|
| Time Factors | 3 | 2016 | 3771 | 0.140 |
Why?
|
| Women's Rights | 1 | 2018 | 6 | 0.140 |
Why?
|
| Universities | 1 | 2019 | 158 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 200 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 32 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2018 | 257 | 0.140 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2017 | 20 | 0.140 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 433 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2019 | 117 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2020 | 379 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 102 | 0.130 |
Why?
|
| Microinjections | 3 | 2004 | 69 | 0.130 |
Why?
|
| Papillomavirus Vaccines | 1 | 2017 | 69 | 0.130 |
Why?
|
| Oligonucleotides | 1 | 1998 | 221 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 141 | 0.130 |
Why?
|
| Intelligence | 1 | 2016 | 52 | 0.130 |
Why?
|
| Gluconeogenesis | 1 | 2016 | 15 | 0.130 |
Why?
|
| California | 1 | 2016 | 174 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 458 | 0.120 |
Why?
|
| RNA Polymerase I | 2 | 2023 | 9 | 0.120 |
Why?
|
| DNA, Ribosomal | 2 | 2010 | 32 | 0.120 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 129 | 0.120 |
Why?
|
| Philosophy | 1 | 2016 | 12 | 0.120 |
Why?
|
| Book Reviews as Topic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Developing Countries | 1 | 2016 | 94 | 0.120 |
Why?
|
| RNA Stability | 1 | 2016 | 102 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 1998 | 390 | 0.120 |
Why?
|
| Hydrodynamics | 1 | 2015 | 37 | 0.120 |
Why?
|
| Genetic Loci | 1 | 2016 | 116 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 489 | 0.120 |
Why?
|
| Medicine | 1 | 2016 | 57 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1353 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 673 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 47 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 371 | 0.110 |
Why?
|
| X-Ray Diffraction | 1 | 2014 | 61 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 575 | 0.110 |
Why?
|
| Drosophila | 1 | 2017 | 433 | 0.110 |
Why?
|
| Oocytes | 2 | 2006 | 198 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 38 | 0.110 |
Why?
|
| Puromycin | 1 | 2013 | 4 | 0.100 |
Why?
|
| Anniversaries and Special Events | 1 | 2013 | 14 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 130 | 0.100 |
Why?
|
| Dactinomycin | 1 | 2013 | 10 | 0.100 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2013 | 8 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 168 | 0.100 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2013 | 23 | 0.100 |
Why?
|
| Fluorescein | 1 | 2013 | 13 | 0.100 |
Why?
|
| Luminescent Proteins | 2 | 2005 | 128 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 896 | 0.100 |
Why?
|
| Caffeine | 1 | 2013 | 50 | 0.100 |
Why?
|
| Deoxyribonucleoproteins | 1 | 2012 | 4 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2005 | 93 | 0.090 |
Why?
|
| Protein Binding | 2 | 2008 | 1603 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 664 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2013 | 114 | 0.090 |
Why?
|
| Cell Nucleus Division | 1 | 2011 | 2 | 0.090 |
Why?
|
| Intranuclear Space | 1 | 2011 | 5 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2004 | 394 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 263 | 0.090 |
Why?
|
| Neurosciences | 1 | 2011 | 27 | 0.090 |
Why?
|
| Writing | 1 | 2011 | 44 | 0.090 |
Why?
|
| Speech | 1 | 2011 | 63 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 936 | 0.080 |
Why?
|
| Rous sarcoma virus | 1 | 2009 | 3 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 642 | 0.080 |
Why?
|
| Cell-Free System | 1 | 2009 | 31 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 988 | 0.080 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 24 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2009 | 65 | 0.080 |
Why?
|
| Massachusetts | 1 | 2015 | 2075 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2009 | 47 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2009 | 292 | 0.070 |
Why?
|
| Oxidoreductases | 3 | 1973 | 64 | 0.070 |
Why?
|
| Diffusion | 2 | 2005 | 82 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 402 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 37 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Fund Raising | 1 | 2006 | 7 | 0.070 |
Why?
|
| RNA, Messenger, Stored | 1 | 2006 | 5 | 0.070 |
Why?
|
| RNA, Archaeal | 1 | 2006 | 2 | 0.060 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2006 | 3 | 0.060 |
Why?
|
| Archaea | 1 | 2006 | 9 | 0.060 |
Why?
|
| Sweden | 1 | 2006 | 58 | 0.060 |
Why?
|
| Bivalvia | 1 | 2006 | 20 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2007 | 82 | 0.060 |
Why?
|
| Korea | 1 | 2006 | 9 | 0.060 |
Why?
|
| Microsomes, Liver | 4 | 1973 | 21 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 319 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 178 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 374 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 251 | 0.060 |
Why?
|
| Leadership | 1 | 2008 | 206 | 0.060 |
Why?
|
| Nuclear Pore | 1 | 2005 | 23 | 0.060 |
Why?
|
| Phosphorus | 1 | 2005 | 16 | 0.060 |
Why?
|
| Nitrogen | 1 | 2005 | 27 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2005 | 110 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2005 | 67 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1148 | 0.060 |
Why?
|
| Myosins | 1 | 2006 | 114 | 0.060 |
Why?
|
| Temperature | 2 | 2004 | 307 | 0.060 |
Why?
|
| Light | 1 | 2005 | 202 | 0.060 |
Why?
|
| Cell Division | 1 | 2006 | 450 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 111 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 204 | 0.060 |
Why?
|
| Polymers | 1 | 2008 | 325 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 245 | 0.060 |
Why?
|
| Cricetinae | 2 | 2004 | 367 | 0.060 |
Why?
|
| Ribonuclease P | 1 | 2004 | 2 | 0.050 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2004 | 3 | 0.050 |
Why?
|
| ran GTP-Binding Protein | 1 | 2004 | 5 | 0.050 |
Why?
|
| Primates | 1 | 2004 | 51 | 0.050 |
Why?
|
| Stem Cells | 1 | 2006 | 259 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2004 | 71 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2004 | 28 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2003 | 38 | 0.050 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2003 | 2 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2003 | 10 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 60 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 166 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 157 | 0.050 |
Why?
|
| Nucleolus Organizer Region | 1 | 2002 | 7 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 863 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2003 | 135 | 0.050 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2001 | 15 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2001 | 20 | 0.050 |
Why?
|
| Ecdysone | 1 | 2001 | 15 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 435 | 0.040 |
Why?
|
| Europe | 1 | 2002 | 195 | 0.040 |
Why?
|
| Bacteriophage T7 | 1 | 2001 | 22 | 0.040 |
Why?
|
| Liver | 2 | 2005 | 855 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 172 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 1973 | 219 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 131 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 32 | 0.040 |
Why?
|
| Male | 2 | 2015 | 29899 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2001 | 612 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 68 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 202 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2020 | 98 | 0.040 |
Why?
|
| Heterochromatin | 1 | 2020 | 89 | 0.040 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 9 | 0.040 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1999 | 13 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 658 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2001 | 263 | 0.040 |
Why?
|
| Ribonuclease T1 | 1 | 1999 | 3 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1999 | 6 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 32 | 0.040 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1999 | 11 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 99 | 0.040 |
Why?
|
| Origin Recognition Complex | 1 | 2018 | 3 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 20 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 173 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2018 | 19 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 676 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 400 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 239 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 149 | 0.030 |
Why?
|
| Autoantigens | 1 | 2018 | 137 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 325 | 0.030 |
Why?
|
| Computational Biology | 2 | 2013 | 356 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 741 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 873 | 0.030 |
Why?
|
| Peroxides | 2 | 1972 | 11 | 0.030 |
Why?
|
| Oxygen | 2 | 1973 | 317 | 0.030 |
Why?
|
| S Phase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 1973 | 11 | 0.030 |
Why?
|
| Adrenochrome | 1 | 1972 | 1 | 0.020 |
Why?
|
| Epinephrine | 1 | 1972 | 44 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 81 | 0.020 |
Why?
|
| Mice | 1 | 2005 | 10843 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1990 | 11 | 0.020 |
Why?
|
| Renin | 1 | 1990 | 10 | 0.020 |
Why?
|
| Blood Cells | 1 | 1970 | 17 | 0.020 |
Why?
|
| Sharks | 1 | 1970 | 7 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1990 | 702 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1198 | 0.010 |
Why?
|
| Cytochrome c Group | 3 | 1973 | 25 | 0.010 |
Why?
|
| Cytochrome Reductases | 2 | 1973 | 3 | 0.010 |
Why?
|
| Alu Elements | 1 | 2003 | 9 | 0.010 |
Why?
|
| Free Radicals | 2 | 1973 | 19 | 0.010 |
Why?
|
| NADP | 2 | 1972 | 23 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1973 | 326 | 0.010 |
Why?
|
| Superoxide Dismutase | 2 | 1973 | 225 | 0.010 |
Why?
|
| Poly T | 1 | 1999 | 2 | 0.010 |
Why?
|
| Poly A | 1 | 1999 | 26 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1999 | 54 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 921 | 0.010 |
Why?
|
| Deoxycholic Acid | 2 | 1973 | 7 | 0.010 |
Why?
|
| Phenobarbital | 2 | 1973 | 12 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1973 | 7 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1973 | 18 | 0.010 |
Why?
|
| Benzofurans | 1 | 1973 | 11 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1973 | 65 | 0.010 |
Why?
|
| Milk | 1 | 1973 | 43 | 0.010 |
Why?
|
| Liposomes | 1 | 1973 | 105 | 0.010 |
Why?
|
| Copper | 1 | 1973 | 51 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1972 | 24 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1972 | 42 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1972 | 16 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 89 | 0.010 |
Why?
|
| Catalysis | 1 | 1972 | 161 | 0.010 |
Why?
|
| Iron | 1 | 1972 | 148 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1972 | 490 | 0.010 |
Why?
|
| Cricetulus | 1 | 1990 | 99 | 0.010 |
Why?
|
| Nucleosides | 1 | 1970 | 11 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 231 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1990 | 383 | 0.010 |
Why?
|
| Leucine | 1 | 1970 | 61 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1973 | 3 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1973 | 5 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1973 | 35 | 0.000 |
Why?
|
| Membranes | 1 | 1973 | 18 | 0.000 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1973 | 30 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1973 | 52 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1973 | 187 | 0.000 |
Why?
|
| Solubility | 1 | 1973 | 180 | 0.000 |
Why?
|
| Rabbits | 1 | 1973 | 333 | 0.000 |
Why?
|